NYSE$HNGE
Hinge Health Inc · Q3 2025 earnings
Q3 2025 earnings · · Investor relations
Briefing
Hinge Health reported Q3 2025, revenue of $154.2M, a net loss of $1.8M.
For Q3 2025, Hinge Health reported revenue of $154.2M, a net loss of $1.8M. The filing highlights segment trends, liquidity, and management commentary on the period.
- Revenue $154.2M.
- Net loss $1.8M.
- Hinge Health discusses capital allocation and near-term priorities.
Headline financials
Revenue & EPS history
Hinge Health, Inc. · Revenue · Quarterly
$154M
Forward guidance
Management discusses operating priorities, capital allocation, and sector-specific risks in the quarterly filing.
Tailwinds
- Headline results and segment commentary anchor the quarter.
- Balance sheet and liquidity support ongoing operations.
- Strategic initiatives cited in MD&A.
Headwinds
- Macro, rates, or input costs may pressure margins.
- One-time items can affect year-over-year comparability.
- Execution risk on guidance or restructuring plans.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 3 quarterly earnings reports · overlaid with Q3 2025
+7.3%
Avg return
Earnings day
+9.1%
Avg return
5 days after
+15.0%
Avg return
30 days after
75%
3 / 4 earnings
Positive
+17.3%
Q4 2025
Best reaction
-1.6%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.4% | +15.3% | +29.3% | |
| Q4 2025 | +17.3% | +17.8% | +36.2% | |
| Q3 2025 | -1.6% | +2.8% | -2.5% | |
| Q2 2025 | +11.3% | +0.3% | -3.2% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro